-
Product Insights
NewProstaglandin G/H Synthase 2 – Drugs In Development, 2024
The Prostaglandin G/H Synthase 2 pipeline drugs market research report outlays comprehensive information on the Prostaglandin G/H Synthase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Immunology, Musculoskeletal Disorders, and Oncology which include indications of Pain, Post-Operative Pain, Inflammation, Rheumatoid Arthritis, Osteoarthritis, Muscle Spasm, Solid Tumor, and Non-Small Cell Lung Cancer. It also...
-
Product Insights
NewProstaglandin G/H Synthase 1 – Drugs In Development, 2024
The Prostaglandin G/H Synthase 1 pipeline drugs market research report outlays comprehensive information on the Prostaglandin G/H Synthase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Immunology, Musculoskeletal Disorders, and Cardiovascular which include indications of Pain, Post-Operative Pain, Inflammation, Rheumatoid Arthritis, Osteoarthritis, Muscle Spasm, Patent Ductus Arteriosus, and Myocardial Infarction. It also reviews...
-
Product Insights
NewG Protein Coupled Bile Acid Receptor 1 – Drugs In Development, 2024
The G Protein Coupled Bile Acid Receptor 1 pipeline drugs market research report outlays comprehensive information on the G Protein Coupled Bile Acid Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Dermatology, Immunology, and Infectious Disease which include indications of Type 2 Diabetes, Obesity, Atopic Dermatitis (Atopic Eczema), Inflammation, Unspecified Immunological Disorders, Sepsis,...
-
Product Insights
NewMas Related G Protein Coupled Receptor MRG – Drugs In Development, 2024
The Mas Related G Protein Coupled Receptor MRG pipeline drugs market research report outlays comprehensive information on the Mas Related G Protein Coupled Receptor MRG targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Genetic Disorders, Central Nervous System, and Musculoskeletal Disorders which include indications of Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – G-207 in Gliosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - G-207 in Gliosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. G-207 in Gliosarcoma Drug Details: G-207 is under development for high-grade glioma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – G-207 in Ependymoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - G-207 in Ependymoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. G-207 in Ependymoma Drug Details: G-207 is under development for high-grade glioma...
-
Product Insights
NewATP Binding Cassette Sub Family G Member 2 – Drugs In Development, 2024
The ATP Binding Cassette Sub Family G Member 2 pipeline drugs market research report outlays comprehensive information on the ATP Binding Cassette Sub Family G Member 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Triple-Negative Breast Cancer (TNBC). It also reviews key players involved in ATP Binding Cassette...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – G-207 in Supratentorial Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - G-207 in Supratentorial Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. G-207 in Supratentorial Glioma Drug Details: G-207 is under development for...
-
Innovation Ranking
Innovation Ranking – KT&G Corp
KT&G Corp (KT&G) produces, distributes and sells tobacco, ginseng, health food, cosmetics and pharmaceuticals products. The company’s products portfolio consists of red ginseng, food and beverages, over-the-counter medicines and medical supplies and equipment’s. It also distributes materials related to tobacco business. KT&G markets these products under various brands including, Esse, Carnival, Bohem, Raison, This, Tonino Lamborghini, Time, and Pine. _x000D_ It is also involved in real estate, rental and house development business, leaf tobacco cultivation and trading related activities. The...
-
Innovation Ranking
Innovation Ranking – Orion Corp(G)
Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson’s disease, chronic obstructive pulmonary disease, and various cancer types. Orion’s client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its...